Naik Meditechs & Devices

Facts & Figures about Diabetes

Diabetes is reaching epidemic proportions. Worldwide, the number of cases is expected to double to 300 million in less than 25 years. Today, over 5 million people worldwide live with Type 1 diabetes (the more severe form of the disease), of which almost 395,000 are children.
If left untreated, long-term complications of the disease can lead to heart failure, blindness, impotence, kidney failure, amputation, and in many cases death. Tight glycaemic control is central to good health, as proven by numerous studies, including the landmark Diabetes Control and Complications Trial (DCCT), which concluded in 1993.

• India - over 35 million are affected making it the diabetic capital of the world and approx 2 - 3% have Type 1 diabetes
• Every fourth diabetic in the world today is an Indian.
• Indians are genetically more susceptible to diabetes and the number of diabetics in India would go up to 40 million by 2010 and 74 million by 2025
• Diabetes is a life-threatening condition.One in 20 deaths is attributable to diabetes; 8,700 deaths every day; six deaths every minute
• Diabetes has become one of the major causes of premature illness and death in most countries, mainly through the increased risk of cardiovascular disease (CVD). Cardiovascular disease is responsible for between 50% and 80% of deaths in people with diabetes.

What is Diabetes?

Diabetes prevents the body from properly using energy from food. The condition occurs when the pancreas produces little or no insulin, a hormone required to sustain life, or when the pancreas makes insulin, but the body resists it.

• Insulin, a hormone required to sustain life
  Insulin is a hormone produced by the Pancreas to aid accessing to the energy stored in the food. Largely this results from the ability of the body, under the influence of Insulin, to release sugar from the food intake, to store it and to use it, when needed, to drive our normal functions.
  

• The normal stability of blood sugar levels
  The normal metabolic process of releasing glucose from the food intake ensures that the amount of sugar in our blood remains within the region of 3.5 to 4.5 mmol/l(60-80 mg/100ml). Insulin levels rise when we have a meal in order to capture the sugar from the food intake. Insulin levels reduce after the processing of the food intake over a period of approximately 2 hours. During the rest of the day, an associated mechanism prevents blood sugar levels from falling below the normal levels by releasing glucose from the body storage areas in fat and tissues.

• The Diabetes disease
  Diabetes is a description of the condition where there is a mismatch between the food intake and the levels of production or utilisation of Insulin.
  • In Type 1 diabetes, the pancreas no longer produces insulin, an important hormone that helps metabolise glucose and supply energy to cells. A person with this condition must administer insulin using injections or an insulin pump.
  • Type 2 diabetes is a metabolic disorder resulting from the body's inability to make enough, or properly use, insulin. Type 2 diabetes is often controlled by diet and exercise, oral medications and, in some cases, insulin. Research indicates that obesity and weight gain are associated with an increased risk of Type 2 diabetes. Insulin pumps have been successfully used to treat Type 2 patients requiring insulin and with poor glycaemic control.

Without an adequate availability of insulin, a person is unable to get energy from food or to keep glucose levels in balance. Poor glucose control can lead to acute complications from hypoglycaemia (low blood glucose) or hyperglycaemia (a condition associated with higher-than-normal blood glucose), which can lead to ketoacidosis, causing coma or death, if left untreated. Diabetes is the leading cause of blindness, kidney failure and amputation, and is a major factor in cardiovascular disease and nerve damage.

Therapy Options

Depending on the type and stage of the disease, different treatment options currently exist:

For people with Type 2 diabetes who do not require insulin administration, the treatment usually mainly consist in:

• Diet and exercise
• Oral medications

For people with Type 1 diabetes, and those with Type 2 diabetes who require Insulin administration, the treatment consists in insulin injection and requires monitoring the blood sugar level. The difficulty lies in making the best match of insulin dosage and food uptake, along with the normal energy requirements of people's day-to-day living.

• Monitoring blood sugar levels
• A treatment regime
• Insulin administration

Monitoring blood sugar levels
In practice, matching Insulin dosage with food uptake requires to see what blood sugar levels are like as well as to identify each patient's patterns in blood sugar swings.

A treatment regime
A treatment regime will normally incorporate target levels for blood sugars at different times of the day, with a balance being achieved by better matching the amount of insulin in accordance with a suitable diet. The aim of any treatment regime, however, is to maintain blood sugar levels as close as possible to normal levels.

Insulin administration

"Take control of your Diabetes so that your Diabetes does not take control of you"

Unregulated high levels of blood sugar are clearly implicated in several conditions. The complications of poorly controlled Diabetes are the single largest cause of End Stage Kidney Failure and loss of vision. The most comprehensive study carried out in this area, the Diabetes Control and Complications Trial (DCCT), which concluded in 1993, came to the clear conclusion that: "Over a life time, DCCT-defined intensive therapy reduces complications, improves quality of life, and can be expected to increase length of life".

• Intensive Conventional Therapy (ICT)
  The evidence is that Intensive Conventional Therapy (ICT) can achieve an appropriate control of blood sugar levels in most individuals who take the trouble to adhere to the requirements. For most people this has meant an increase in the number of injections, often up to four or five per day, along with much more diligent monitoring of blood sugars.
• Continuous Subcutaneous Insulin Infusion (CSII)
  Insulin pumps, which provide treatment referred to as Continuous Subcutaneous Insulin Infusion are an excellent tool for helping people improve glycaemic control. It is especially indicated in cases where ICT has not achieved good results.
  Insulin pumps have been shown to improve glucose control for many patients and can provide a better quality of life than injection therapies. An insulin pump is able to more closely mimic the action of a pancreas by continuously delivering small doses of insulin, even while a patient sleeps. This is extremely important, as poor glucose control can lead to long-term complications of diabetes, such as blindness, kidney failure, nerve damage, amputation and heart disease.
  To learn more on Pump therapy.

Over 70 abstracts and articles on the usage and experience with the CGMS system have been published since the product's introduction in 1999. In fact, successful results from a pilot study were published in the December 1999 issue of Diabetes Research and Clinical Practice, and indicated that patients' HbA1c levels were reduced an average of more than 1% after only five weeks following use of the CGMS system (Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Research and Clinical Practice 1999;46:183-190). The lead investigator of the pilot study noted that HbA1c levels had never before been lowered so quickly and that therapy adjustments resulting in this reduction would not have been made on the basis of intermittent information obtained through traditional glucose meters. Furthermore, a 10 week follow up showed that HbA1c levels remained as low or lower, without any additional intervention by the healthcare team, thus demonstrating the sustainability of these results.

Insulin Pump Therapy

What is an insulin pump?
An insulin pump is a small, battery-operated device (about the size of a pager) that can replace insulin injections for patients managing diabetes. The purpose of a pump is to provide an accurate, continuous controlled delivery of insulin, in pulses which can be regulated by the user to meet their Glucose control objectives.

How does an insulin pump work?
The pump delivers insulin from a reservoir inside the pump, through a thin plastic tube (called an infusion set), to the body. Most infusion sets are worn in the abdominal area and use a tiny, flexible tube, called a cannula, which is inserted easily into the skin using an insertion device. Patients generally refill their insulin and change their infusion sets every two to three days.

A pump is easy to program and automatically delivers a constant rate of insulin - called a "basal rate"- to keep blood glucose in the desired range between meals and over night. Guided by a physician, the user creates a customized basal pattern, with the goal of closely matching individual needs. Pump users can easily adjust the pump for changes in lifestyle needs, and can program insulin delivery at mealtimes.

• Pump therapy is simple. It is based on what your body does naturally - deliver small pulses of insulin all the time and little extras controlled by the patient at mealtimes to cover the food intake.

• The pump helps achieve "tight glucose control." Diabetes patients can easily adjust insulin to keep glucose levels within a near-normal range. A pump can help patients avoid hyperglycaemia (high blood sugar), which can degrade health over time, and hypoglycaemia (low blood sugar), an acute condition that can be very dangerous, particularly at night while a patient sleeps.

• The pump more closely mimics a healthy pancreas. An insulin pump more closely mimics a healthy pancreas by delivering insulin effectively, continuously and with minimal variability. A healthy pancreas delivers insulin every 10 to 14 minutes. A pump more closely mimics the pancreas by continually delivering insulin around the clock and allowing patients to program multiple basal rates depending on their individual needs.

• The pump is precise and accurate. Insulin pumps can deliver insulin precisely and accurately in 0.1 unit increments, which is nearly impossible for people using traditional injection therapy.

• With the pump, people can be more flexible. Unlike patients using longer-acting insulin with injection therapy who must follow rigid schedules of insulin injections, meals and snacks, patients using an insulin pump can program insulin delivery when they eat, and adjust or stop insulin delivery for exercise or other needs. Patients using pump therapy can eat what they want, when they want -- something almost unheard of in patients treating their condition with traditional insulin injections.

Why good control is important?

Better blood glucose control has been the focus of a lot of attention since the release of the results of the landmark Diabetes Control and Complications Trials (DCCT) in 1993. The DCCT was the largest long-term research study on the effects of glucose control ever conducted. There were two groups of subjects in the study. One group managed their diabetes using "conventional" methods (1 - 2 injections per day and 1 - 2 daily blood glucose tests), while the other half used "intensive" methods, with frequent blood glucose monitoring and daily adjustments of food and insulin to keep blood glucose as near normal as possible. Nearly half in the intensively treated group used insulin pumps to help them achieve that level of control. The chart shows the differences in control that the different styles of treatment produced.

The DCCT showed clearly that those who achieved a better blood sugar control with an average 2% lower glycohemoglobin value had a tremendous decrease in their risk for the long-term complications of diabetes. Risk of diabetic eye disease was decreased by 76% and reductions in risk for kidney and nerve damage were nearly as great. Obviously, diabetes control matters... a LOT. In fact, these results were so significant that the DCCT investigators felt compelled to end the study one year early so the conventionally treated patients could have the opportunity to realize the benefits of intensive diabetes management.

An insulin pump is a good way to achieve the degree of control now known to be the best defense against long-term health problems.

Diagnostic Products

• AVANTI^®+ Sheath Introducer

For use in arterial and venous procedures requiring percutaneous introduction of intravascular devices, the AVANTI^®+ Introducer is the pioneer of catheter sheath introducer technology. Featuring a patented SLIX Valve, the AVANTI^®+ Introducer provides smooth transitions, monitoring capabilities and exceptional performance for your procedural success, as well as:

• • A hexacuspid design that provides a balance between catheter maneuverability and hemostasis.
  • A rotating suture collar that facilitates greater procedural flexibility. It stays in place better and allows more patient movement.
  • A kink-resistant cannula design integrating a soft, flexible inner layer with a stiffer outer layer for improved bendability and support. It is also less prone to kinking, cost-effective and reliable.
  • Atraumatic tip transitions for both the sheath and the vessel dilator are uniquely tapered and manicured. This results in smooth insertions and may help lessen damage upon entry
• EMERALDâ„¢ Diagnostic Guidewire

Intended for percutaneous entry and guidance of catheters, the EMERALD^â„¢ Diagnostic Guidewire complements our diagnostic catheter and catheter sheath introducer lines. Performance, endurance and safety are built into each EMERALD^â„¢ Guidewire with solid tensile strength to minimize the likelihood of stretching or fracturing.

Product highlights:

• • Enhanced maneuverability
  • Reduced likelihood of flaking
  • Finger straightenability
  • Precise tolerances
  • Proprietary PTFE Coating Process
  • Available in multiple shapes and sizes
•  INFINITI^® Diagnostic Catheter

The INFINITI^® 4F, 5F, and 6F line of diagnostic catheters is ideal for coronary angioplasty. These catheters incorporate proprietary Vestan^â„¢ Nylon to deliver exceptional responsiveness and flow rates, optimal torque, and shape retention.

---

Access Products

• VISTA BRITE TIP^® Guiding Catheters

An innovation in cardiac catheterization, VISTA BRITE TIP^® Guiding Catheters are indicated for the delivery of interventional devices to coronary or peripheral vascular systems.

Cordis offers a complete line of Extra Backup Guides for both the left and right coronary arteries, and a complete line of specialty guides to suit special case needs.

---

Steerable Guidewires

---

Interventional Products

• CYPHER^® Sirolimus-eluting Coronary Stent

The CYPHER^® Sirolimus-eluting Coronary Stent is an interventional therapy that has been shown to dramatically improve clinical outcomes. Since the arrival of stents in 1995, in-stent restenosis (a reblockage within the stent) has proven to be the major limitation of interventional cardiology, occurring in approximately 10-40% of patients*. CYPHER^® Stents are specifically designed to reduce in-stent restenosis.

CYPHER^® Stents are small, spring-like metal stents coated with the drug sirolimus. The drug-eluting stents also include a polymer coating that controls the timed release of the drug inside the vessel.

Since its launch, more than 3,000,000 patients have been treated worldwide with CYPHER^® Stents. For more information please visit CypherStent.com

• FIRE STAR^® PTCA Dilatation Catheters

The FIRE STAR^® Dilatation Catheter is designed to provide crossability with accuracy for balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion.

• • Long balloon shaft – 145 cm
  • Stainless steel hypotube
  • Integrated hypotube clip
  • Snap-fit gripper
  • Choice of single or dual market bands in 1.5/2.0 diameters
•  DURA STAR^® PTCA Dilatation Catheters

The DURA STAR^® Dilatation Catheter is a high-pressure balloon catheter system providing accuracy with crossability.

The DURA STAR^® Catheter is used for balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion. It also is indicated for post-delivery expansion of balloon-expandable stents.

The DURA STAR^® Catheter offers:

Note: Bench-top testing was performed with the DURA STAR^® Rx PTCA Dilatation Catheter along with marketed Cordis balloon-expandable stents. Caution should be taken when using this device with stents of other manufacturers, due to stent design differences.

LowerExtremity Solutions

• FRONTRUNNER^® XP CTO Catheter

The FRONTRUNNER^® XP CTO Catheter enables controlled crossing of Chronic Total Occlusions (CTOs), using blunt microdissection to create a channel through the occlusion to facilitate wire placement.

FRONTRUNNER^® XP CTO Catheters offer:

• • Low profile. Features a crossing profile of .039" with actuating jaws that open to 2.3 mm.
  • Lubricious, hydrophilic coating along the entire catheter length to facilitate CTO crossing.
  • Catheter steerability. The shapeable distal tip and effective torque control enhance maneuverability and catheter steerability.
  • Integrated system. Variable support from advancing and retracting the 4.5F Micro Guide Catheter.
• OUTBACK^® LTD^® Re-Entry Catheter

The OUTBACK^® LTD^® Re-Entry Catheter enables fast and simple true lumen re-entry technology without the need for IVUS visualization.

The OUTBACK^® LTD^® Re-Entry Catheter offers:

• • Low profile, 6F sheath compatible
  • Highly visible "L" and "T" markers. Orient the re-entry cannula toward the true lumen easily, eliminating the need for additional visualization equipment.
  • Effective torque control. Positions the OUTBACK^® LTD^® Re-Entry Catheter toward the target re-entry site.
  • On average eight minutes to gain re-entry. Potentially reduces radiation exposure time and may help increase procedure volume.
  • Lubricious, hydrophilic coating along the entire catheter length to facilitate subintimal passage.
  • Easy to use. Requires no additional capital equipment or time-consuming set-up.
• AQUATRACK^® Hydrophilic Guidewires

The AQUATRACK^® Guidewire facilitates access to the most tortuous anatomy, providing the control, visibility and exceptional design symmetry that enable you to torque and maneuver through difficult lesions.

AQUATRACK^® Guidewires offer:

• • Superior torque. A nitinol wire with torque response like a stainless steel guidewire, for greater turn responsiveness than the Terumo Glidewire^® and superior multi-vessel selection and lesion crossability.
  • Lasting lubricity. Excellent guide and device support, with a smooth ride from start to finish.
  • Superior radiopacity. Shorter procedure times and fewer complications, by seeing your every move.
• TEMPO^® AQUA^® Hydrophilic-Coated Diagnostic Catheter

TEMPO^® AQUA^® Diagnostic Catheter is an angiographic catheter providing excellent flow rates and optimal contrast delivery and vessel opacification.

TEMPO^® AQUA^® Catheters offer:

• • Precise control and sturdy support. High-strength nylon construction and braided shaft design give strength and flexibility for superb torque response and maximum tactile control.
  • Enhanced tip radiopacity. An extended, tungsten-filled NEON^® tip, with superb visualization for rapid and precise catheter placement. Less need for contrast injection.
  • Flexible tip. Patented soft design and long non-braided distal end increases tip flexibility, helps reduce risk of vessel trauma and promotes patient comfort.
  • Microcatheter compatibility. Compatible with Codman Neurovascular RAPIDTRANSIT^® and PROWLER^® Microcatheters, as well as REGATTA^® Steerable Guidewire.
  • Smoother delivery. Hydrophilic SLX^® Coating minimizes friction between the catheter and the vessel wall for rapid and smooth vessel engagement.
• SLEEK^® RX PTA Dilatation Catheters

Specially designed for infrapopiteal vessels, SLEEK^® RX Catheters deliver precision, speed and control in groundbreaking lengths.

Innovative design produces the first-ever 220mm length balloons for treating long, diffuse disease with fewer inflations. SLEEK^® RX Catheters also provide trackability in a rapid-exchange platform, which enables single-operator use with shorter guidewires. QuadFlex^® balloon material combines flexibility, durability, and predictable compliance.

Other characteristics of SLEEK^® RX Catheters include:

Excellent Deliverability

Specific sizes for infrapopliteal vessels

• • 2-4mm balloon diameters
  • 40-220mm balloon lengths
  • 150+cm shaft lengths for reaching distal vessels
• SAVVY^® Long PTA Dilatation Catheters

Delivering precision and control in crossing and treating complex SFA and infrapopliteal lesions, Cordis SAVVY^® Long PTA Dilatation Catheters are now available in balloon lengths up to 220mm.

Key Features include:

• • Pushability and a smooth, low crossing profile providing the ability to successfully access the lesion. Every detail of the Cordis SAVVY^® Long Catheter is designed with a single goal in mind: accuracy with fewer inflations.
• Unique legacy of short shoulders leading to precise treatment of target lesion.
• • Low profile 4 Fr sheath compatibility
  • Lubricious SLX^® Coating.
  • OTW 0.018†enhances pushability
• S.M.A.R.T.^® CONTROL^® Iliac Stent System

First Nitinol Iliac Stent Indicated for Primary Stenting of Common and External Iliac Arteries

S.M.A.R.T.^® CONTROL^® Iliac Stent Results*

The S.M.A.R.T.^® CONTROL^® Iliac Stent System delivers notable patient results*

Tantalum MicroMarker^® Technology

Flared Stent Ends

MicroMesh Geometry and Segmented Design

Cordis TRUMARK^® Technology

Cordis S.M.A.R.T.^® CONTROL^® Stent Delivery Handle

Radiopaque Marker Band

• OPTA^® Pro PTA Dilatation Catheter

The OPTA^® Pro Catheter is the everyday choice for efficient renal and leg intervention and features:

• • DURALYN^® high performance balloon material
  • • Puncture and abrasion resistant
    • Controlled compliance for accurate balloon vessel sizing
    • Short shoulders
• Outstanding delivery
• • Through a 6F sheath introducer (select sizes)
• 5F dual-lumen shaft
• • Includes single dedicated inflation lumen for rapid inflation/deflation times
• Gold marker bands
• • For excellent stent placement accuracy
• Optimal-rated burst pressure
• • 10 atm (3mm-10mm) and 6 atm (12mm) with a nominal pressure of 6 atm (3mm-10mm) and 4 atm (12mm)
• Flexible, tapered tip
• • Combined with a low profile system leading to excellent trackability when crossing tighter lesions.

---

Carotid Stent Systems 

• PRECISE^® PRO RX^® Carotid Stent System

PRECISE^® PRO RX^® Stent is the industry benchmark carotid stenting system, used increasingly by physicians to perform Carotid Artery Stenting as an option for patients at high risk for surgery.

PRECISE^® PRO RX^® Stent offers:

• ANGIOGUARD^® RX Emboli Capture Guidewire System

The Cordis ANGIOGUARD^® RX Guidewire System is the first embolic protection device shown in clinical testing to achieve a relative stroke reduction of 70% during carotid stenting procedures.*

ANGIOGUARD^® RX Guidewire System offers:

---

VENA CAVA FILTERS

• TRAPEASE^® Permanent Vena Cava Filter

TRAPEASE^® Permanent Vena Cava Filter offers a range of unique advantages:

One TRAPEASE^® Filter provides more options:

• • 90cm kit allows filter delivery through six entry sites (right and left femoral, jugular, and antecubital veins)
  • 55cm kit allows filter delivery through four entry sites (right and left femoral and jugular veins)
  • No need to change systems when changing access sites
  • Unique symmetrical filter design reduces inventory and costs
• OPTEASE^® Retrievable Vena Cava Filter

OPTEASE^® Retrievable Vena Cava Filters are an innovative option for prevention of recurrent pulmonary embolism, representing the next generation of filters for the next generation of patients. It offers all the proven strengths of the Cordis TRAPEASE^® Permanent Vena Cava Filter plus the additional option of retrieval.

OPTEASE^® Retrievable Vena Cava Filters offer:

One OPTEASE^® Retrievable Vena Cava Filter kit provides more options:

Cordis VISEASE^® Angiographic Vessel Dilator simplifies pre-placement venacavogram

Cordis BRITE TIP^® Interventional Sheath 6F (8F OD) provides flexibility and support for easy tracking through tortuous vessels

Hypertension, the new killer of the new Economy....

Due to globalisation and a stressful working environment hypertension threatens to wallop the work force in India. According to a survey, 65 million people were affected by hypertension in 2008 in India and that in the years ahead it was likely to see a quantum leap of over 135 million to touch a figure of 200 million by 2015.

India is losing its potentially productive years due to increasing heart diseases, strokes and diabetes in the age group of 35-60, one of the highest in the world, according to the report.

In the absence of proper facilities to mitigate propensities leading to tensions and high blood pressures, chronic diseases accounted for 53 per cent of deaths in the country and this was expected to go up to 60 per cent by 2015 and 66 per cent by 2020. According to the report, 4 million deaths in 1990 were due to chronic diseases and the same was likely to touch a figure of 7 million by 2015.

What Should I Do?

There is a saying which goes like..... TO CONTROL SOMETHING, YOU FIRST NEED TO MEASURE IT!!!

OMRON range of BP Monitors, provide you with a perfect tool to do just that. Accurate and easy to use, it enables you to monitor you BP independently at the touch of a button...Thats right...No more mercury sypghmomanometers and stethoscope weilding assistants to be at your side to record your BP. You can do it yourself at the touch of a button. What's more? Our diverse range of BP monitors allow you to record upto 90 sets of readings with date and time, have a hypertension indicator, detects and reports body movements while taking the reading*, detects irregular heartbeats*, gives a good battery life and also has provision for DC adaptor thereby avoiding the need to replace batteries^.

* IA2 Model only, ^ SEM1, IA2 Model only

Models Available in India (ARM Type)

Models Available in India (WRIST Type)

COMPARE BP MONITORS (Click to Compare)

EAR Thermometers

Gentle Temp Instant Ear Thermometer measures body temperature from the ear. Clinical research has shown that the ear is an ideal site for taking body temperature. Enhanced sensor technology is applied for accurate measurements that meet ASTM standards (American Society for testing Material)

Models Available in India

Oral, Rectal, Under Arm Thermometers

Accurate, Easy to use and available at the right price, OMRON digital thermometer is a must have for every home.

Models Available in India

Are you a fitness freak or health conscious individual?

If the answer to the above question is yes, you would be a frequent user of the weighing scale. Not satisfied with the reading on the weighing scale you might have gone on to calculate the BMI and then gone on to rate yourself as under weight, normal, obese or very obese and tuned your fitness programs accordingly. So far so good..But do you know that while BMI is one of the measure to evaluate your fitness, its not completely reliable.

What is BMI?

BMI is a formula that estimates a person’s body fat using only his/her weight and height. The result is then used to determine weight categories: 18.5 and below is considered underweight; 18.6-24.9 healthy; 25-29 overweight and 30+ obese.

BMI is NOT the right measure....

Bone mass and muscle mass varies from person to person. So two people aged 30 years and weighing 85 Kgs might have completely different fitness levels. The reason is that the bone mass, muscle mass (both known as lean mass)and fat mass varies from person to person depending on his physical activity level and food habits.

Also the scale was created years ago and is based on Caucasian men and women. It doesn’t take into account differences in body composition between genders, race/ethnicity groups, and across the lifespan.

It has been proven that BMI, the number used to indicate weight category does not reflect the same amount of body fat for some races compared to others.

Therefore its very crital to evaluate the % of body fat present in the indivudual before one can classify him as underweight, normal, obese or very obese. How do you go about doing that? There two very accurate tests that can help calculate your body fat % in the body accurately.

1. Hydrostatic Testing
   Hydrostatic Testing (Underwater Weighing) has become universally regarded by industry experts as the "Gold Standard" in body fat testing. It works on the fact that bone, muscle, and connective tissue collectively known as lean mass sinks, while body fat floats is the main principle behind (hydro-densitometry) hydrostatic testing. By obtaining your land weight and water weight (based on buoyancy), your body fat as a percentage of your total weight can be scientifically calculated.
2. DXA Method In this method, dual-energy x-ray absorptiometry, which is a low dose x-ray known as DXA, is used to determine percent fat. DXA can be used to estimate bone density, lean mass and fat mass. The DXA method uses two different frequency X-Rays and rates of absorption of the body and determines the value based on the difference between the two.

What is the Bioelectrical Impedance method?

Muscles, blood vessels and bones are body tissues having a high water content that conduct electricity easily. Body fat is tissue that has little electric conductivity. Omron Body fat monitor sends an extremely weak electrical current of 50 kHz and less than 500 µA through your body to determine the amount of fat tissue. This weak electrical current is not felt while operating the BF400. The Bioelectrical Impedance Method safely combines the electric resistance with the distance of the electricity conducted. Correct posture and consistent measuring conditions need to be maintained for the best results.

DXA (Dual Energy X-Ray Absorptiometry), has been the established method for accurate evaluation of body composition. OMRON has used research information from several hundred people using the DXA method to develop the formula by which the body fat monitors work. The body fat mass and body fat percentage is calculated by a formula that includes five factors: electric resistance, height, weight, age and gender.

Models Available in India

COMPARE BODY FAT MONITORS (Click to Compare)

An OMRON pedometer is a great motivational tool to track your distance, the number of steps you take and how many calories you burn. You can easily set and reach your daily goals.

It works even in your pocket and bag! You do not need to clip onto your belt or pants with this, it's convenient and easy to use. No sensitivity adjustment needed.

Models Available in India

Omron Healthcare utilizes the latest technologies to improve the management and treatment of asthma and other respiratory diseases.

Models Available in India (Compressor Nebulizers)

Models Available in India (Ultrasonic Nebulizers)

• Hand and skin disinfectant
• Disinfection of instruments
• Detergents
• Surfaces and medical equipment
• Spray-disinfection of surfaces
• Hand-wash products
• Mouth hygiene
• Wash lotions and baths
• Care for the hands and skin
• Protection of the skin
• Prevention and control of skin fungus
• Accessories